Intravenous saline 0.9% — Competitive Intelligence Brief

Intravenous saline 0.9% (Intravenous saline 0.9%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid / Electrolyte replacement. Area: Fluid and electrolyte management / Critical care.

marketed Crystalloid fluid / Electrolyte replacement Fluid and electrolyte management / Critical care Small molecule

Target snapshot

Intravenous saline 0.9% (Intravenous saline 0.9%) — University of Nottingham. Intravenous saline 0.9% restores fluid and electrolyte balance by delivering isotonic sodium chloride solution directly into the bloodstream.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Intravenous saline 0.9% TARGET	Intravenous saline 0.9%	University of Nottingham	marketed	Crystalloid fluid / Electrolyte replacement
Sterile isotonic saline solution	Sterile isotonic saline solution	Hospital Italiano de Buenos Aires	marketed	Crystalloid fluid / Electrolyte replacement solution
Isotonic NaCl	Isotonic NaCl	Hvidovre University Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
Saline Solution (NaCl 0,9%)	Saline Solution (NaCl 0,9%)	Université du Québec à Trois-Rivières	marketed	Crystalloid fluid / Electrolyte replacement
IV Saline bolus and infusion	IV Saline bolus and infusion	University of Auckland, New Zealand	marketed	Crystalloid fluid / Electrolyte replacement
% 0.9 Saline solution	% 0.9 Saline solution	Kecioren Education and Training Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
Normal Saline 0.9% Infusion Solution Bag	Normal Saline 0.9% Infusion Solution Bag	Vanderbilt University Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid / Electrolyte replacement class)

1. University of Auckland, New Zealand · 2 drugs in this class
2. Fundacion Clinica Valle del Lili · 1 drug in this class
3. Montefiore Medical Center · 1 drug in this class
4. Rhode Island Hospital · 1 drug in this class
5. Rigshospitalet, Denmark · 1 drug in this class
6. Seoul National University Hospital · 1 drug in this class
7. Universidad Nacional de La Plata · 1 drug in this class
8. University of Nottingham · 1 drug in this class
9. Dalarna County Council, Sweden · 1 drug in this class
10. Université du Québec à Trois-Rivières · 1 drug in this class